Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
XpressBio, officially Express Biotech International, is a private life sciences company based in Frederick, Maryland that manufactures and markets molecular and immunological products for the bioscience research community. Its catalog includes ELISA assays, coated binding microplates, biomarker assays, antibodies, antigens, ADME assay kits, gene-editing research tools, HIV/SIV research products, and animal health monitoring reagents. The company appears to operate primarily as a research tools and assay supplier rather than a drug developer, and its products are designated for research use only, not for diagnostic or human therapeutic use. XpressBio serves pharmaceutical, biotechnology, government, and academic customers worldwide and emphasizes custom assay development and specialized ELISA expertise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on XpressBio.